Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-470-7 | CAS number: 107-18-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A total of three key studies have been identified, assessing acute toxicity in the rat following oral and inhalatory exposure and in the rabbit following dermal exposure.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 99 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 89 mg/kg bw
Additional information
Acute oral toxicity: a method similar to OECD guideline 401 was used. Five male rats were used for each dose group and observed for 10 days post exposure. The main clinical findings were apathy, anxiety, diarrhoea and coma. Gross pathology findings confirm oedema and congestion of the lungs, visceral congestion, discoloured liver (with some necrosis) and swollen discoloured kidneys. The LD50 was determined to be 99 -105 mg/kg. A supporting study (oral administration to rabbits) gave a comparable result: LD50 71 (42 -125) mg/kg
Acute inhalation toxicity: Two studies were identified as having assessed the acute inhalation toxicity of allyl alcohol. The better conducted, key study (performed under GLP) used 10 animals (5 male, 5 female) per dose with whole-body inhalation exposure for 1, 4 and 8 hours at concentrations of 0, 10, 20, 50, 100, 200 and 400 ppm allyl alcohol vapour. Animals were observed over a 14 -day period and surviving animals necropsied. Clinical effects noted included gasping, reddened ears, forelimbs and/or hindlimbs, red or clear material around the mouth and on ventral abdominal or urogentical surfaces in all dose groups.
A weak sedating effect was also seen in the 4 -hour exposure group at doses of 50ppm and 100ppm and also in the 8 -hour exposure group at doses of 20ppm and 50ppm.
Histopathological examination revealed: in 1-hour exposure groups: reversible nasal cavity changes. Degeneration of the olfactory epithelium, metaplasia of olfactory epithelium, chronic inflammation and haemorrhage. In 4-hour exposure groups: reversible nasal cavity changes. Degeneration of respiratory epithelium, degeneration of olfactory epithelium, chronic inflammation and goblet cell hyperplasia. In 8-hour exposure groups: reversible nasal cavity changes (degeneration, erosion, degeneration and erosion of the respiratory epithelium, chronic inflammation, haemorrhage and hyperplasia of goblet cells) plus in 2 males irreversible changes (ulceration, respiratory metaplasia, severe degeneration of olfactory epithelium), with 1 rat dying. With only one death, no LC50 value was determined, but the 4h LC50 value was clearly >100 ppm (237.6 mg/cu.m).NOAEL values for lethality or irreversible effects in tbis study were:
1 -hour exposure, 400 ppm
4 -hour exposure, 100 ppm
8 -hour exposure, 20 ppm (males), 50 ppm (females).
The supporting acute inhalation study predated GLP but did follow an accepted test procedure. 6 rats were exposed to concentrations of 40 - 2300 ppm allyl alcohol vapour for 1, 4 and 8 hours and subsequently observed for 10 days. Histopathological findings include lung congestion, liver damage (congestion and necrosis of periportal sinusoids, central pallor and necrosis), presence of heme casts and cloudy swelling in the kidney. LC50 values of 1060, 165, 76 ppm were obtained for male rats exposed to allyl alcohol vapour by inhalation for 1, 4, 8 hours respectively.
Acute dermal toxicity: One key study was identified as having assessed the dermal toxicity of allyl alcohol. The study followed a method similar to OECD guideline 402. Four groups of 3 rabbits were exposed to concentrations of 25 - 200 mg/kg allyl alcohol in occlusive dressing. The main clinical findings were apathy, flushing of the skin with ataxia and diarrhoea preceding death in moribund animals. Gross pathology findings include, oedema and congestion of lungs, visceral congestion (presence of mucous in intestinal tract), discoloured liver, swollen kidneys. The LC50 was determined to be 89 mg/kg.
Justification for classification or non-classification
Acute oral toxicity
Based on the results of the key study (oral LD50 99 - 105 mg/kg), allyl alcohol should be classified as:
- under Directive 67/548/EEC criteria, T - R25 (Toxic if swallowed)
- under UN GHS criteria, Acute Toxicity Category 3 (Toxic if swallowed )
- under Regulation 1272/2008 (EU CLP GHS) criteria, Acute Toxicity Category 3 (Toxic if swallowed).
the DSD and CLP classifications cited above are in accord with those listed for allyl alcohol in
Annex VI of the CLP Regulation (EC No. 1272/2008).
Acute inhalation toxicity
No precise LC50 value was determined in the key study. The supporting study (Dunlap et al., 1958) for allyl alcohol reports a 4-hour LC50 of 165 ppm, which approaches the high end of the Acute toxicity Cat 1 rating. However, the 4-hour NOAEC for lethality in the key study was 100 ppm, and a 1-hour NOAEC for lethality of 400 ppm, which would imply that Cat 1 is likely to be overly conservative. Acute toxicity Cat 2 is proposed. The current entry for allyl alcohol given in Annex VI of the CLP Regulation (EC No. 1272/2008): allyl alcohol is Acute toxicity Cat. 3, inhalation route with an asterisk which indicates the minimum classification. Since the data demonstrates that a more severe classification is appropriate, Acute toxicity Category 2 will be applied to this substance.
Acute dermal toxicity
Based on the results of the key study (rabbit dermal LD50 89 mg/kg), allyl alcohol should be classified as:
- under Directive 67/548/EEC criteria, T - R24 (Toxic in contact with skin)
- under UN GHS criteria, Acute Toxicity Category 2 (Fatal in contact with skin)
- under Regulation 1272/2008 (EU CLP GHS) criteria, Acute Toxicity Category 2 (Fatal in contact with skin).
In Annex VI of the CLP Regulation (EC No. 1272/2008) allyl alcohol is classified as Acute toxicity Cat. 3 (dermal route) with an asterisk which indicates this is the minimum classification to be applied. Since the data indicates that a more severe classification is appropriate, Acute Toxicity Category 2 via the dermal route will will be applied.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.